CAPITAL RAISING

SINGAPORE, ASIA, AUSTRALIA

INVESTMENT DEALFLOW

SINGAPORE, ASIA, AUSTRALIA

ASIA GATEWAY - MARKET ENTRY SERVICES

SINGAPORE, ASIA, AUSTRALIA

CAPITAL RAISING & INVESTMENT DEAL FLOW IN ASIA

CAPITAL RAISING – INVESTMENT DEALFOW – PRIVATE EQUITY

Ventures International Group is a Singapore-based Capital Raising and Private Equity firm. It specializes in assisting its Capital Raising clients to obtain Private Equity and Debt funding from its investors in Singapore, Australia, Asia, and Globally. Ventures International Group prides itself on being a source of quality Investment Deal Flow and Investment Opportunities for the Family Offices, Private High Net Worth Investors, and Funds which form part of its Investor Network.

Ventures International Group also provides Strategic Advisory services, as well as “Asia Gateway” Market Entry Services to companies seeking to start or expand their business in Singapore/Asia. The company has its headquarters in Singapore and a presence in Sydney and Bangkok, together with a network of investors and business contacts across Asia.

CURRENT INVESTMENT OPPORTUNITIES

HEALTHCARE SERVICES - EQUITY - USD $2M-$4M

PROPERTY - DEBT - AUD UP TO $20M+

A leading Australian Residential Development Group specializing in the strategic acquisition, development and management of highly cash-flow positive property in a rapidly growing and high yielding region of Australia. Various investment options.

FOOD & BEVERAGE (FAST-FOOD OPERATOR) – DEBT/EQUITY – SGD $5M+

INVESTMENT COMPANY – SHARES – SGD $5M

Singapore Investment Company with a diverse portfolio of Emerging Stage companies with global potential:

INTERNET – ONLINE GAMING/GAMBLING – EQUITY – UP TO $5M

Innovative Social Gaming and Gambling internet technology company with fully developed technology platform,develops and operates online gaming and licensed gambling platforms, poised for global launch:

HEALTHCARE – MEDICAL DEVICE – EQUITY – GBP 5M (UP TO 15M)

UK-based Medical Device Company has just received CE (European market certification) for its unique and revolutionary therapeutic patient monitoring device in a global market segment second only to glucose monitoring using blood diagnostics: